0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,250USDGBP
From
EUR$4,750USDGBP
From
EUR$4,850USDGBP
Human Insulin Drugs Market in Brazil 2024-2028 - Product Thumbnail Image

Human Insulin Drugs Market in Brazil 2024-2028

  • Report
  • December 2023
  • 142 Pages
  • Brazil
From
EUR$2,500USDGBP
From
EUR$3,500USDGBP
From
EUR$3,500USDGBP
From
EUR$4,000USDGBP
From
EUR$4,000USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,450USDGBP
Smart Insulin Pens Market - Product Thumbnail Image

Smart Insulin Pens Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
EUR$4,150USDGBP
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more